By Heather Hobbs
BRINGING YOU THE LATEST NEWS & EVENTS FROM THE SCIENCE INDUSTRY Industry Event to drive Innovation and Sustainability
Lab Innovations, which returns to NEC Birmingham in Autumn 2022, is set to showcase the latest breakthroughs in technology and the best sustainable lab equipment and practices. Taking place on 2-3 November this leading UK event will bring together industry professionals, scientists and researchers, with many premium exhibitors, including Shimadzu, Avantor and Scientific Laboratory Supplies already confirmed..
Visitors can also gain insight into data-driven case studies, which this year will feature equipment and processes used to reduce a lab’s environmental impact.
“Lab Innovations is a great opportunity for end users to see how our equipment works in a real laboratory environment and how the data we’ve collected can be replicated in their own labs to help them to be more sustainable,” explained Andy Evans, Director at Green Light Labs and host of Lab Innovations’ Sustainable Laboratory.
Also featured wll be the Lab Awards, which will celebrate the key achievements of the laboratory industry in four categories: Innovation, Sustainability, Automation and Collaboration.
Attendees at this year’s show can also earn CPD points from four free-to-attend theatre programmes – the Royal Society of Chemistry Theatre, the Insights & Innovation Theatre, the Cleanroom Hub and Live Lab.
The show will be co-located with Advanced Engineering, which is supported by key industry associations such as The Institution of Engineering and Technology (IET), Composites UK, Make UK and the Institution of Mechanical Engineers. This helps to promote cross-sector collaboration and continued innovation by the UK’s leading laboratory and engineering industries.
Alison Willis, Director at Easyfairs, the organiser of Lab Innovations said: “More than ever
last year’s exhibitors and attendees were keen to do business at the show, having missed interacting in-person for nearly two years.” Registration is now open.
More information online:
ilmt.co/PL/lBAE 58125pr@reply-direct.com
Validating the role of Hydrolysates in Biotherapeutics Manufacturing
“This research will enable an understanding of the functional role of hydrolysates in cell culture media that will promote the efficient production of biotherapeutics from bioprocesses.” Michael Butler
Biotherapeutics manufacture at a commercial scale is a complex process involving the growth of mammalian cells in a multi-component liquid media containing bioactive components, which can be sourced from plant and microbial sources such as soy, yeast, cotton and wheat.
These components are chemically undefined and contain complex composition dependent on the raw material used, making cell culture media one of the most difficult components to control.
Kerry Group, a supplier of commercialised breakdown products of proteins, or hydrolysates, for use in cell cultures along with the National Institute for Bioprocessing Research and Training (NIBRT) and ValitaCell have announced a strategic collaboration to validate the role of protein hydrolysates in cell culture media during commercial manufacture
The Laboratory of Michael Butler at NIBRT (Credit: NIBRT)
of biotherapeutics. The project is supported by Enterprise Ireland under the Innovation Partnership programme.
Vivien Sheehan, Global VP RD&A & Regulatory AH&N at Kerry Group commented: “We at Kerry are delighted to collaborate with NIBRT & ValitaCell to further enhance our understanding of our hydrolysates. ValitaCell’s novel Chemstress®
platform and NIBRTs expertise will support in developing this understanding and help Kerry in producing the next generation of plant & microbial based hydrolysates for the production of biotheraputics. We are thankful for the continued support from Enterprise Ireland for Kerry’s research and development activities across multiple end use markets.”
Biotechnology company ValitaCell will provide access to its Chemstress®
platform,
to characterise the behaviour of cells using a panel of specific, small molecule chemical stressors. The assay is carried out on a multiwell plate and enables the rapid screening of the robustness of cells within the specific environment of each well.
Dr Jerry Clifford, CEO at ValitaCell remarked: “ValitaCell have invested significant resources in our Chemstress platform to provide scientists with a Biological prism of their manufacturing
environment, in microscale. Working with Kerry Group and NIBRT on this specific validation problem is a great opportunity to demonstrate the power of our technology in the Cell Culture media component sector.”
The programme of work will be conducted at the NIBRT, University College of Dublin, under the guidance of Professor Michael Butler, Principal Investigator in the Cell Technology Group at NIBRT who said: “We are delighted at NIBRT to receive funding from Enterprise Ireland in collaboration with the Kerry Group and ValitaCell to enable a study of the bioactive properties of plant and microbial sourced hydrolysates using the Chemstress platform technology. This research will enable an understanding of the functional role of hydrolysates in cell culture media that will promote the efficient production of biotherapeutics from bioprocesses.”
More information online:
ilmt.co/PL/vP4A
58150pr@reply-direct.com Collaboration seeks Insights into Molecular Interaction
Researchers from Queen’s University Belfast and Trinity College Dublin have uncovered how positrons – key to PET scan technology – interact with molecules, offering potential for research in advancing materials in science and medical imaging technology.
Antimatter, considered rare and exotic, is abundant and provides an extremely challenging theoretical problem that must be solved if scientists are to progress fundamental research and applications in medical imaging technology and material science.
The research teams have been able to develop a powerful theoretical and computational approach that has successfully explained more than 20 years’ worth of measurements and which can now be used to predict how positrons interact with other molecules.
Dr Dermot Green from the School of Mathematics and Physics at Queen’s led the research. He commented: “Until now, scientists have struggled to properly explain how antimatter interacts with molecules – it is a formidably complex area of research and science. Our breakthrough provides fundamental understanding of these interactions, unprecedented accuracy, and the ability to make predictions, which may help support fundamental physics and develop antimatter-based applications in materials science and medical imaging.”
Dr Charles Patterson from the School of Physics at Trinity College Dublin developed the Exciton software that he and the Queen’s University group adapted - creating Exciton+ - to perform the calculations in the work.
He said: “I developed the Exciton code over many years to enable me to study how materials absorb and emit light for applications
such as light emitting diodes and solar cells. I am delighted that Dermot Green and his group were able to adapt the code to study how positrons interact with molecules. Many-body physics is a fascinating area of research with many important applications.”
The research was funded by a European Research Council grant ANTI-ATOM. The team of researchers included Jaroslav Horfierka (Queen’s University PhD student and joint-first author), Brian Cunningham (Queen’s University Research Fellow and joint-first author), Charlie Rawlins (Queen’s University Research Fellow) and collaborator Dr Charles Patterson from Trinity College Dublin.
The research was published in Nature More information online:
ilmt.co/PL/JpVV
58164pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
